These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24690159)

  • 21. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
    Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
    Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
    Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
    Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke.
    Havasi V; Szolnoki Z; Talián G; Bene J; Komlósi K; Maász A; Somogyvári F; Kondacs A; Szabó M; Fodor L; Bodor A; Melegh B
    J Mol Neurosci; 2006; 29(2):177-83. PubMed ID: 16954607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome.
    Maász A; Kisfali P; Horvatovich K; Mohás M; Markó L; Csöngei V; Faragó B; Járomi L; Magyari L; Sáfrány E; Sipeky C; Wittmann I; Melegh B
    Pathol Oncol Res; 2007; 13(3):243-7. PubMed ID: 17922054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of obesity related to total energy intake with the APOA5-1131T > C polymorphism in Korean premenopausal women.
    Lim HH; Choi M; Kim JY; Lee JH; Kim OY
    Nutr Res; 2014 Oct; 34(10):827-36. PubMed ID: 25263629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291).
    Sharma V; Witkowski A; Witkowska HE; Dykstra A; Simonsen JB; Nelbach L; Beckstead JA; Pullinger CR; Kane JP; Malloy MJ; Watson G; Forte TM; Ryan RO
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2254-60. PubMed ID: 25127531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitution of red meat with legumes in the therapeutic lifestyle change diet based on dietary advice improves cardiometabolic risk factors in overweight type 2 diabetes patients: a cross-over randomized clinical trial.
    Hosseinpour-Niazi S; Mirmiran P; Hedayati M; Azizi F
    Eur J Clin Nutr; 2015 May; 69(5):592-7. PubMed ID: 25351652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
    Zaki M; Amr K
    Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. -1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.
    Sóter MO; Gomes KB; Fernandes AP; Carvalho Md; Pinheiro PS; Bosco AA; Silva DD; Sousa MO
    Mol Biol Rep; 2012 Jul; 39(7):7541-8. PubMed ID: 22350263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
    Niculescu LS; Vlădică M; Sima AV
    Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients.
    Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B
    Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene transfer of apolipoprotein A-V improves the hypertriglyceridemic phenotype of apoa5 (-/-) mice.
    Sharma V; Beckstead JA; Simonsen JB; Nelbach L; Watson G; Forte TM; Ryan RO
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):474-80. PubMed ID: 23329134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study.
    Cardona F; Guardiola M; Queipo-Ortuño MI; Murri M; Ribalta J; Tinahones FJ
    Atherosclerosis; 2009 Sep; 206(1):148-52. PubMed ID: 19344899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The apolipoprotein A5 gene -1131T-->C polymorphism affects vitamin E plasma concentrations in type 2 diabetic patients.
    Girona J; Guardiola M; Cabré A; Manzanares JM; Heras M; Ribalta J; Masana L
    Clin Chem Lab Med; 2008; 46(4):453-7. PubMed ID: 18302531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphism of apolipoprotein A5 is a risk factor for cerebral infarction in type 2 diabetes.
    Li X; Xu Y; Ding Y; Qin C; Dai Z; Niu L
    J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):653-6. PubMed ID: 19107359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
    Qi L; Liu S; Rifai N; Hunter D; Hu FB
    Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges.
    Martin S; Nicaud V; Humphries SE; Talmud PJ;
    Biochim Biophys Acta; 2003 Apr; 1637(3):217-25. PubMed ID: 12697303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
    Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
    Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.